{"id":"https://openalex.org/W3012385461","doi":"https://doi.org/10.1200/jco.2013.31.15_suppl.2530","title":"Combination of a MEK inhibitor, pimasertib (MSC1936369B), and a PI3K/mTOR inhibitor, SAR245409, in patients with advanced solid tumors: Results of a phase Ib dose-escalation trial.","display_name":"Combination of a MEK inhibitor, pimasertib (MSC1936369B), and a PI3K/mTOR inhibitor, SAR245409, in patients with advanced solid tumors: Results of a phase Ib dose-escalation trial.","publication_year":2013,"publication_date":"2013-05-20","ids":{"openalex":"https://openalex.org/W3012385461","doi":"https://doi.org/10.1200/jco.2013.31.15_suppl.2530","mag":"3012385461"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2013.31.15_suppl.2530","doi":"https://doi.org/10.1200/jco.2013.31.15_suppl.2530","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2013.31.15_suppl.2530","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5064382279","display_name":"Rebecca Suk Heist","orcid":"https://orcid.org/0000-0002-7397-2009","observed_orcids":["https://orcid.org/0000-0002-7397-2009"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rebecca Suk Heist","raw_affiliation_strings":["Massachusetts General Hospital, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital, Boston, MA","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020504047","display_name":"Leena Gandhi","orcid":"https://orcid.org/0000-0002-2398-9179","observed_orcids":["https://orcid.org/0000-0002-2398-9179"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Leena Gandhi","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045419282","display_name":"Geoffrey Ira Shapiro","orcid":"https://orcid.org/0000-0002-3331-4095","observed_orcids":["https://orcid.org/0000-0002-3331-4095"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Geoffrey Shapiro","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075877134","display_name":"Naiyer A. Rizvi","orcid":"https://orcid.org/0000-0002-1134-7494","observed_orcids":["https://orcid.org/0000-0002-1134-7494"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Naiyer A. Rizvi","raw_affiliation_strings":["Memorial Sloan-Kettering Cancer Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan-Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072308451","display_name":"Howard A. Burris","orcid":"https://orcid.org/0000-0002-1501-2931","observed_orcids":["https://orcid.org/0000-0002-1501-2931"]},"institutions":[{"id":"https://openalex.org/I4210135086","display_name":"Tennessee Oncology","ror":"https://ror.org/03754ky26","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210135086"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Howard A. Burris","raw_affiliation_strings":["Sarah Cannon Research Institute; Tennessee Oncology, Nashville, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sarah Cannon Research Institute; Tennessee Oncology, Nashville, TN","institution_ids":["https://openalex.org/I4210135086"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028472820","display_name":"Johanna C. Bendell","orcid":"https://orcid.org/0000-0001-9426-5891","observed_orcids":["https://orcid.org/0000-0001-9426-5891"]},"institutions":[{"id":"https://openalex.org/I4210135086","display_name":"Tennessee Oncology","ror":"https://ror.org/03754ky26","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210135086"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Johanna C. Bendell","raw_affiliation_strings":["Sarah Cannon Research Institute; Tennessee Oncology, Nashville, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sarah Cannon Research Institute; Tennessee Oncology, Nashville, TN","institution_ids":["https://openalex.org/I4210135086"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004300577","display_name":"Jose M Baselga","orcid":"https://orcid.org/0000-0003-1361-4063","observed_orcids":["https://orcid.org/0000-0003-1361-4063"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jose Baselga","raw_affiliation_strings":["Memorial Sloan-Kettering Cancer Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan-Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082542972","display_name":"Scott B Yerganian","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Scott B Yerganian","raw_affiliation_strings":["Memorial Sloan-Kettering Cancer Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan-Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072906560","display_name":"Karl Hsu","orcid":"https://orcid.org/0000-0003-3137-1202","observed_orcids":["https://orcid.org/0000-0003-3137-1202"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Karl Hsu","raw_affiliation_strings":["Sanofi-Aventis, Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sanofi-Aventis, Cambridge, MA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079155002","display_name":"Janet Ogden","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210111614","display_name":"EMD Serono, Inc. (United States)","ror":"https://ror.org/027zrs220","country_code":"US","type":"company","lineage":["https://openalex.org/I164928964","https://openalex.org/I4210111614"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Janet Ogden","raw_affiliation_strings":["EMD Serono, Inc., Billerica, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"EMD Serono, Inc., Billerica, MA","institution_ids":["https://openalex.org/I4210111614"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Lo\u00efc Vincent","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3018075036","display_name":"Sanofi (France)","ror":"https://ror.org/02n6c9837","country_code":"FR","type":"company","lineage":["https://openalex.org/I3018075036"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Lo\u00efc Vincent","raw_affiliation_strings":["Sanofi Oncology, Vitry-sur-Seine, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sanofi Oncology, Vitry-sur-Seine, France","institution_ids":["https://openalex.org/I3018075036"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022988657","display_name":"Oliver von Richter","orcid":"https://orcid.org/0000-0002-5262-9922","observed_orcids":["https://orcid.org/0000-0002-5262-9922"]},"institutions":[{"id":"https://openalex.org/I164928964","display_name":"Merck KGaA, Darmstadt (Germany)","ror":"https://ror.org/04b2dty93","country_code":"DE","type":"company","lineage":["https://openalex.org/I164928964"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Oliver von Richter","raw_affiliation_strings":["Merck KGaA, Darmstadt, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck KGaA, Darmstadt, Germany","institution_ids":["https://openalex.org/I164928964"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001666583","display_name":"Giuseppe Locatelli","orcid":"https://orcid.org/0000-0002-2179-4407","observed_orcids":["https://orcid.org/0000-0002-2179-4407"]},"institutions":[{"id":"https://openalex.org/I164928964","display_name":"Merck KGaA, Darmstadt (Germany)","ror":"https://ror.org/04b2dty93","country_code":"DE","type":"company","lineage":["https://openalex.org/I164928964"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Giuseppe Locatelli","raw_affiliation_strings":["Merck KGaA, Darmstadt, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck KGaA, Darmstadt, Germany","institution_ids":["https://openalex.org/I164928964"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108248511","display_name":"Ekatherine Asatiani","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210113211","display_name":"Merck Serono S.A. (Switzerland)","ror":"https://ror.org/01vp49361","country_code":"CH","type":"company","lineage":["https://openalex.org/I164928964","https://openalex.org/I4210113211"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Ekatherine Asatiani","raw_affiliation_strings":["Merck Serono S.A., Geneva, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck Serono S.A., Geneva, Switzerland","institution_ids":["https://openalex.org/I4210113211"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5103514741","display_name":"Jeffrey R. Infante","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210135086","display_name":"Tennessee Oncology","ror":"https://ror.org/03754ky26","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210135086"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffrey R. Infante","raw_affiliation_strings":["Sarah Cannon Research Institute; Tennessee Oncology, Nashville, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sarah Cannon Research Institute; Tennessee Oncology, Nashville, TN","institution_ids":["https://openalex.org/I4210135086"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":8,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":28,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"31","issue":"15_suppl","first_page":"2530","last_page":"2530"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.0017999999690800905,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.001500000013038516,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pimasertib","display_name":"pimasertib","score":0.9639999866485596},{"id":"https://openalex.org/keywords/mek-inhibitors","display_name":"MEK inhibitors","score":0.8389999866485596},{"id":"https://openalex.org/keywords/pi3k-mtor-inhibitors","display_name":"PI3K/mTOR inhibitors","score":0.9929999709129333},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.7310000061988831},{"id":"https://openalex.org/keywords/advanced-solid-tumors","display_name":"advanced solid tumors","score":0.8799999952316284},{"id":"https://openalex.org/keywords/mapk-signaling","display_name":"MAPK signaling","score":0.671999990940094},{"id":"https://openalex.org/keywords/pi3k-akt-mtor-pathway","display_name":"PI3K/AKT/mTOR pathway","score":0.8410000205039978},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.8450000286102295},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.9300000071525574},{"id":"https://openalex.org/keywords/recommended-phase-ii-dose","display_name":"recommended phase 2 dose","score":0.8560000061988831},{"id":"https://openalex.org/keywords/colorectal-cancer","display_name":"colorectal cancer","score":0.8650000095367432},{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.9539999961853027},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9819999933242798},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.871999979019165},{"id":"https://openalex.org/keywords/kras-mutation","display_name":"KRAS mutation","score":0.9039999842643738}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9156942367553711},{"id":"https://openalex.org/C2778570526","wikidata":"https://www.wikidata.org/wiki/Q653197","display_name":"Rash","level":2,"score":0.6761556267738342},{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.6688979864120483},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6030144095420837},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.5372092723846436},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5001871585845947},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.47757986187934875},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.4523516595363617},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.43477392196655273},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.41568806767463684},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3971383273601532}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2013.31.15_suppl.2530","doi":"https://doi.org/10.1200/jco.2013.31.15_suppl.2530","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2013.31.15_suppl.2530","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2090657374","https://openalex.org/W2956607982","https://openalex.org/W2588419540","https://openalex.org/W2905870549","https://openalex.org/W2265743937","https://openalex.org/W3106155507","https://openalex.org/W2041930762","https://openalex.org/W1996458873","https://openalex.org/W2899848123","https://openalex.org/W1592490241"],"abstract_inverted_index":{"2530":[0],"Background:":[1],"PI3K/mTOR":[2,25],"and":[3,52,78,102,144,153,167,204,213,265,269,294,303,319,323],"MAPK":[4],"signaling":[5],"pathways":[6,16],"are":[7,332],"often":[8],"deregulated":[9],"in":[10,42,120,234,307],"tumors.":[11,48],"Simultaneous":[12],"inhibition":[13],"of":[14,317,327],"these":[15],"with":[17,45,272],"the":[18,23,55,85,118,188,191,221],"MEK1/2":[19],"inhibitor,":[20,26],"pimasertib,":[21],"plus":[22],"dual":[24,127],"SAR245409,":[27],"(ClinicalTrials.gov":[28],"NCT01390818)":[29],"was":[30,34,91,96,113,185,220],"investigated.":[31],"Methods:":[32],"This":[33],"a":[35],"phase":[36,109],"Ib,":[37],"modified":[38],"3+3,":[39],"dose-escalation":[40],"trial":[41,336],"patients":[43],"(pts)":[44],"advanced":[46],"solid":[47],"Pts":[49],"received":[50],"pimasertib":[51,318],"SAR245409":[53,320],"at":[54,117,205,310],"following":[56],"dose":[57,89,111],"levels":[58],"(DLs):":[59],"DL1,":[60],"15/30;":[61],"DL2a,":[62],"30/30;":[63],"DL2b,":[64],"15/50;":[65],"DL3,":[66],"30/50;":[67],"DL4a,":[68],"60/50;":[69],"DL4b,":[70],"30/70;":[71],"DL5,":[72],"60/70;":[73],"DL6a,":[74],"90/70;":[75],"DL6b":[76,172],"60/90":[77],"DL7,":[79],"90/90":[80],"mg":[81,105],"(once-daily,":[82],"qd).":[83],"After":[84],"qd":[86,152,192,235],"maximum":[87],"tolerated":[88,322],"(MTD)":[90],"established,":[92],"twice-daily":[93],"(bid)":[94],"dosing":[95,316],"tested:":[97],"DL1a,":[98],"60/30;":[99],"DL1b,":[100],"45/50":[101],"DL2":[103],"60/50":[104],"bid.":[106,156],"A":[107],"recommended":[108],"II":[110,330],"(RP2D)":[112],"determined.":[114],"Enrollment":[115,306],"continued":[116],"RP2D":[119,222],"four":[121],"expansion":[122,308],"cohorts":[123,309],"(18":[124],"pts":[125,149,155,174,198,208],"each):":[126],"KRAS/PIK3CA":[128],"mutated":[129],"(mt)":[130],"colorectal":[131],"cancer":[132,142,297],"(CRC),":[133],"triple-negative":[134],"breast":[135],"cancer,":[136],"KRAS":[137,290,300],"mt":[138,291,302],"non-small":[139],"cell":[140],"lung":[141],"(NSCLC)":[143],"BRAFmt":[145],"melanoma.":[146],"Results:":[147],"53":[148],"were":[150,161,286],"treated":[151],"7":[154],"The":[157,229],"most":[158,230],"common":[159,231],"tumors":[160],"CRC":[162,292],"(n=16),":[163],"NSCLC":[164],"(n=8),":[165],"ovarian":[166,296],"pancreatic":[168],"(n=7,":[169],"each).":[170],"At":[171,194],"2/3":[173,207],"had":[175,217],"dose-limiting":[176],"toxicities":[177],"(DLTs;":[178],"both":[179],"grade":[180],"[Gr]":[181],"3":[182,201,210,215],"nausea/vomiting).":[183],"DL6a":[184],"confirmed":[186],"as":[187],"MTD":[189],"for":[190],"schedule.":[193],"bid":[195],"DL1a":[196],"2/4":[197],"(both":[199],"Gr":[200,214,241,246,251,256,261],"skin":[202,211],"rash)":[203],"DL1b":[206],"(Gr":[209],"rash":[212,238],"asthenia)":[216],"DLTs.":[218],"DL5":[219,311],"based":[223],"on":[224],"tolerability":[225],"after":[226],"prolonged":[227],"exposure.":[228],"adverse":[232],"events":[233],"schedule":[236],"were:":[237],"(62%,":[239],"13%":[240],"3),":[242,247,252,257,262],"diarrhea":[243],"(56%,":[244],"4%":[245],"fatigue":[248],"(51%,":[249],"2%":[250,255,260],"nausea":[253],"(49%,":[254],"vomiting":[258],"(45%,":[259],"peripheral":[263],"edema":[264],"pyrexia":[266],"(34%,":[267],"each)":[268],"visual":[270],"impairment":[271],"underlying":[273],"serous":[274],"retinal":[275],"detachment":[276],"(21%).":[277],"Preliminary":[278],"pharmacokinetic":[279],"results":[280],"suggest":[281],"no":[282],"drug-drug":[283],"interaction.":[284],"There":[285],"4":[287],"partial":[288],"responses:":[289],"(n=1)":[293],"low-grade":[295],"(n=3,":[298],"1":[299],"mt/PIK3CA":[301],"2":[304],"wild-type).":[305],"is":[312,321],"ongoing.":[313],"Conclusions:":[314],"Continuousqd":[315],"has":[324],"shown":[325],"signs":[326],"activity.":[328],"Phase":[329],"trials":[331],"being":[333],"planned.":[334],"Clinical":[335],"information:":[337],"NCT01390818.":[338]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-17T09:40:24.721904","created_date":"2020-03-23T00:00:00"}